394 related articles for article (PubMed ID: 30483053)
1. Metabotropic Glutamate Receptors in Glial Cells: A New Potential Target for Neuroprotection?
Spampinato SF; Copani A; Nicoletti F; Sortino MA; Caraci F
Front Mol Neurosci; 2018; 11():414. PubMed ID: 30483053
[TBL] [Abstract][Full Text] [Related]
2. Metabotropic glutamate receptors in neurodegeneration/neuroprotection: still a hot topic?
Caraci F; Battaglia G; Sortino MA; Spampinato S; Molinaro G; Copani A; Nicoletti F; Bruno V
Neurochem Int; 2012 Sep; 61(4):559-65. PubMed ID: 22306345
[TBL] [Abstract][Full Text] [Related]
3. Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.
Maksymetz J; Moran SP; Conn PJ
Mol Brain; 2017 Apr; 10(1):15. PubMed ID: 28446243
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective and symptomatic effects of targeting group III mGlu receptors in neurodegenerative disease.
Williams CJ; Dexter DT
J Neurochem; 2014 Apr; 129(1):4-20. PubMed ID: 24224472
[TBL] [Abstract][Full Text] [Related]
5. Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research.
Litim N; Morissette M; Di Paolo T
Neuropharmacology; 2017 Mar; 115():166-179. PubMed ID: 27055772
[TBL] [Abstract][Full Text] [Related]
6. Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective.
Caraci F; Molinaro G; Battaglia G; Giuffrida ML; Riozzi B; Traficante A; Bruno V; Cannella M; Merlo S; Wang X; Heinz BA; Nisenbaum ES; Britton TC; Drago F; Sortino MA; Copani A; Nicoletti F
Mol Pharmacol; 2011 Mar; 79(3):618-26. PubMed ID: 21159998
[TBL] [Abstract][Full Text] [Related]
7. Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs.
Bruno V; Battaglia G; Copani A; D'Onofrio M; Di Iorio P; De Blasi A; Melchiorri D; Flor PJ; Nicoletti F
J Cereb Blood Flow Metab; 2001 Sep; 21(9):1013-33. PubMed ID: 11524608
[TBL] [Abstract][Full Text] [Related]
8. Glial metabotropic glutamate receptor-4 increases maturation and survival of oligodendrocytes.
Spampinato SF; Merlo S; Chisari M; Nicoletti F; Sortino MA
Front Cell Neurosci; 2014; 8():462. PubMed ID: 25642169
[TBL] [Abstract][Full Text] [Related]
9. Allosteric modulation of metabotropic glutamate receptors in alcohol use disorder: Insights from preclinical investigations.
Johnson KA; Lovinger DM
Adv Pharmacol; 2020; 88():193-232. PubMed ID: 32416868
[TBL] [Abstract][Full Text] [Related]
10. Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia.
Nicoletti F; Orlando R; Di Menna L; Cannella M; Notartomaso S; Mascio G; Iacovelli L; Matrisciano F; Fazio F; Caraci F; Copani A; Battaglia G; Bruno V
Front Psychiatry; 2019; 10():49. PubMed ID: 30890967
[TBL] [Abstract][Full Text] [Related]
11. Identification of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Acting at Site Distinct from 2-Methyl-6-(phenylethynyl)-pyridine Binding.
Butkiewicz M; Rodriguez AL; Rainey SE; Wieting J; Luscombe VB; Stauffer SR; Lindsley CW; Conn PJ; Meiler J
ACS Chem Neurosci; 2019 Aug; 10(8):3427-3436. PubMed ID: 31132237
[TBL] [Abstract][Full Text] [Related]
12. Functional modulation of G-protein coupled receptors during Parkinson disease-like neurodegeneration.
Jenkins BG; Zhu A; Poutiainen P; Choi JK; Kil KE; Zhang Z; Kuruppu D; Aytan N; Dedeoglu A; Brownell AL
Neuropharmacology; 2016 Sep; 108():462-73. PubMed ID: 26581500
[TBL] [Abstract][Full Text] [Related]
13. Metabotropic glutamate receptor-mediated signaling in neuroglia.
Loane DJ; Stoica BA; Faden AI
Wiley Interdiscip Rev Membr Transp Signal; 2012 Mar; 1(2):136-150. PubMed ID: 22662309
[TBL] [Abstract][Full Text] [Related]
14. Targeting of Metabotropic Glutamate Receptors for the Development of Novel Antidepressants.
Chaki S; Koike H; Fukumoto K
Chronic Stress (Thousand Oaks); 2019; 3():2470547019837712. PubMed ID: 32500107
[TBL] [Abstract][Full Text] [Related]
15. New therapeutic frontiers for metabotropic glutamate receptors.
Niswender CM; Jones CK; Conn PJ
Curr Top Med Chem; 2005; 5(9):847-57. PubMed ID: 16178730
[TBL] [Abstract][Full Text] [Related]
16. Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system.
Di Menna L; Joffe ME; Iacovelli L; Orlando R; Lindsley CW; Mairesse J; Gressèns P; Cannella M; Caraci F; Copani A; Bruno V; Battaglia G; Conn PJ; Nicoletti F
Neuropharmacology; 2018 Jan; 128():301-313. PubMed ID: 29079293
[TBL] [Abstract][Full Text] [Related]
17. Activation of group III metabotropic glutamate receptors inhibits the production of RANTES in glial cell cultures.
Besong G; Battaglia G; D'Onofrio M; Di Marco R; Ngomba RT; Storto M; Castiglione M; Mangano K; Busceti CL; Nicoletti FR; Bacon K; Tusche M; Valenti O; Conn PJ; Bruno V; Nicoletti F
J Neurosci; 2002 Jul; 22(13):5403-11. PubMed ID: 12097492
[TBL] [Abstract][Full Text] [Related]
18. Metabotropic glutamate receptors in Parkinson's disease.
Kwan C; Kang W; Kim E; Belliveau S; Frouni I; Huot P
Int Rev Neurobiol; 2023; 168():1-31. PubMed ID: 36868628
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Type 5 Metabotropic Glutamate Receptor: A Potential Therapeutic Strategy for Neurodegenerative Diseases?
Budgett RF; Bakker G; Sergeev E; Bennett KA; Bradley SJ
Front Pharmacol; 2022; 13():893422. PubMed ID: 35645791
[TBL] [Abstract][Full Text] [Related]
20. Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs.
Wierońska JM; Pilc A
Neurochem Int; 2009; 55(1-3):85-97. PubMed ID: 19428811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
